Diabetes Mellitus, Type 2

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician. — Singapore

• The University of Texas Medical Branch (UTMB) — Galveston, Texas, United States

• Joslin Diabetes Center — Boston, Massachusetts, United States

• Insituto Nacional de Enfermedades Respiratorias — Mexico City, Delegacion Tlalpan, Mexico

Not specified

• Park Nicollet Institute / International Diabetes Center, Minneapolis, MN — Minneapolis, Minnesota, United States

• Hospital Universitari Mútua Terrassa — Terrassa, Barcelona, Spain
• Mútua Terrassa Primary Care — Terrassa, Barcelona, Spain
• Hospital Universitari Sant Joan de Reus — Reus, Tarragona, Spain

• Novo Nordisk Investigational Site — Seremban, Negeri Sembilan, Malaysia

• Nagoya Kyoritsu Hospital — Aichi, Nagoya, Japan
• Kashiwa City Hospital — Chiba, Kashiwa, Japan
• Otabe internal medicine clinic — Fukuoka, Fukuoka, Japan
• Nakamura Cardiovascular Clinic — Fukuoka, Itoshima, Japan

• Novo Nordisk Investigational Site — Broadmeadow, New South Wales, Australia
• Novo Nordisk Investigational Site — Coffs Harbour, New South Wales, Australia
• Novo Nordisk Investigational Site — Ipswich, Queensland, Australia
• Novo Nordisk Investigational Site — Fitzroy, Victoria, Australia